Put All of Your Specimens – and All of Their Data – At Your Fingertips, May 4

Fiercebiotech.com

Click here to subscribe to Fiercebiotech.com

7 years ago

Html
Text

This week's FierceBiotech is brought to you by Covance Inc.

If you have trouble reading this email view the online version.

WEBINAR

Turning Biorepositories Into
Translational Science Treasure Troves: The Value of Uniquely Complete Data Sets

Date: Thursday, May 4, 2017 Time: 11 a.m. EDT

Dr. Amelia Warner, Founder/ CEO,
Global Specimen Solutions, Inc. (GSS)

Dear Colleague,
As clinical trials incorporate wider patient populations around the globe and the number of biomarker assays available increases, your specimen biorepositories represent an increasingly valuable resource for translational science.
However, numerous challenges interfere with achieving this reality.

Join Amelia Warner, PharmD, RPh, CEO and Founder, GSS, as she discusses how having the right data at your fingertips can help you: Identify and locate relevant specimens along with complete records, such as result information and informed consent
Overcome the challenges of internal initiatives with ready-to-implement, holistic data management
Transcend data silos to enable unified views of specimen data through real-time analytics
Get pan-pipeline insights to help you bring fresh approaches to your research We hope to see you on the webinar!

Covance and Global Specimen Solutions, Inc. (GSS) have formed a unique strategic alliance, offering new solutions for extracting value from the entire specimen life cycle.

Covance Inc., headquartered in Princeton, NJ, USA is the drug development
business of Laboratory Corporation of America Holdings (LabCorp).
COVANCE is a registered trademark and the marketing name for Covance Inc.
and its subsidiaries around the world.
For more information about Covance, visit us online at www.covance.com. Copyright © 2017 Covance Inc. All rights reserved. Covance Inc., 210 Carnegie Center Princeton, NJ 08540-6233 USA
THE AMERICAS: +1.888.COVANCE (+1.888.268.2623) +1.609.452.4440
EUROPE/AFRICA : +00.800.2682.2682 +44.1423.500888
ASIA PACIFIC: +800.6568.3000 +65.6.5686588

Want to reach 160,000+ FierceBiotech subscribers with your own message?
Contact aalcover@fiercemarkets.com or call 202-824-5074.

About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech.
Click here to unsubscribe.

FierceMarkets, a division of Questex, LLC
1900 L St. NW Suite 400
Washington, DC 20036

Share on

Other newsletters from Fiercebiotech.com

| 11.27.24 | Novartis plots field sales layoffs linked to Xolair, cancer combo; Trump picks Stanford economist to helm NIH Fiercebiotech.com
Yesterday at 19:26
| 11.27.24 | Trump names NIH pick; PTC axes ALS program, gains $150M in voucher sale Fiercebiotech.com
Yesterday at 17:10
| 11.26.24 | Amgen’s obesity data disappoint investo rs; Guardant awarded $292M in false advertising suit Fiercebiotech.com
Last Tuesday at 20:46

More newsletters from Fiercebiotech.com

Put All of Your Specimens – and All of Their Data – At Your Fingertips, May 4

Share on

Other newsletters from Fiercebiotech.com

Related newsletters